Cervical Intraepithelial Neoplasia (CIN) – Pipeline Review, H2 2016


Posted January 4, 2017 by Shirley

Cervical Intraepithelial Neoplasia (CIN) – Pipeline Review, H2 2016, provides an overview of the Cervical Intraepithelial Neoplasia (CIN) (Women’s Health) pipeline landscape.

 
MRRS adds "Cervical Intraepithelial Neoplasia (CIN) – Pipeline Review, H2 2016" latest studies, published in December 2016. It is a professional and in-depth study.

Summary
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cervical Intraepithelial Neoplasia (CIN) – Pipeline Review, H2 2016, provides an overview of the Cervical Intraepithelial Neoplasia (CIN) (Women’s Health) pipeline landscape.

Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia is characterized by abnormal appearance of cells on the surface of the cervix. Cervical dysplasia usually occurs in women aging twenty five to thirty five. Most cases of cervical dysplasia are caused by human papilloma virus (HPV). Factors contributing to cervical dysplasia include using immunosuppressants and smoking. Signs and symptoms include genital warts, abnormal bleeding, spotting after intercourse, vaginal discharge and low back pain.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Cervical Intraepithelial Neoplasia (CIN) (Women’s Health).
– The pipeline guide reviews pipeline therapeutics for Cervical Intraepithelial Neoplasia (CIN) (Women’s Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Cervical Intraepithelial Neoplasia (CIN) (Women’s Health) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Cervical Intraepithelial Neoplasia (CIN) (Women’s Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Cervical Intraepithelial Neoplasia (CIN) (Women’s Health)

Table Of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Cervical Intraepithelial Neoplasia (CIN) Overview 7
Therapeutics Development 8
Pipeline Products for Cervical Intraepithelial Neoplasia (CIN) - Overview 8
Pipeline Products for Cervical Intraepithelial Neoplasia (CIN) - Comparative Analysis 9
Cervical Intraepithelial Neoplasia (CIN) - Therapeutics under Development by Companies 10
Cervical Intraepithelial Neoplasia (CIN) - Therapeutics under Investigation by Universities/Institutes 11
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Cervical Intraepithelial Neoplasia (CIN) - Products under Development by Companies 14
Cervical Intraepithelial Neoplasia (CIN) - Products under Investigation by Universities/Institutes 15
Cervical Intraepithelial Neoplasia (CIN) - Companies Involved in Therapeutics Development 16
CEL-SCI Corp 16
Genexine Inc 17
Inovio Pharmaceuticals Inc 18
PDS Biotechnology Corp 19
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 20
Transgene SA 21
Vaccibody AS 22
Cervical Intraepithelial Neoplasia (CIN) - Therapeutics Assessment 23
Assessment by Monotherapy Products 23
Assessment by Target 24
Assessment by Route of Administration 26
Assessment by Molecule Type 28
Drug Profiles 30
ABI-1968 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
aminolevulinic acid hydrochloride - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
DNA Vaccine to Target E7 for HPV Associated Cancers - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
....

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/cervical-intraepithelial-neoplasia-cin-pipeline-review-h2-2016

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Marketing , Reports
Last Updated January 4, 2017